SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1q9p'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.53A 1c6yA-1q9pA:
11.1		 1c6yA-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
THR A  80
PRO A  81
ILE A  84
 None
 0.51A 1c6yB-1q9pA:
11.3		 1c6yB-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.66A 1c6zA-1q9pA:
10.8		 1c6zA-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.55A 1c6zB-1q9pA:
10.9		 1c6zB-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.45A 1d4sA-1q9pA:
10.3		 1d4sA-1q9pA:
92.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DYR_A_TOPA407_1
(DIHYDROFOLATE
REDUCTASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ALA A  71
LEU A  89
ILE A  13
ILE A  33
ILE A  62
 None
 0.87A 1dyrA-1q9pA:
undetectable		 1dyrA-1q9pA:
20.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.49A 1fb7A-1q9pA:
10.5		 1fb7A-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.68A 1fb7A-1q9pA:
10.5		 1fb7A-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.81A 1hpvB-1q9pA:
10.6		 1hpvB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.56A 1hpvB-1q9pA:
10.6		 1hpvB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.62A 1hsgA-1q9pA:
10.6		 1hsgA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.44A 1hsgB-1q9pA:
10.7		 1hsgB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.81A 1hshA-1q9pA:
10.1		 1hshA-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.43A 1hshC-1q9pA:
9.8		 1hshC-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.73A 1hshC-1q9pA:
9.8		 1hshC-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 1hxbA-1q9pA:
10.5		 1hxbA-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 1hxbA-1q9pA:
10.5		 1hxbA-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 1hxbB-1q9pA:
10.5		 1hxbB-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.63A 1hxbB-1q9pA:
10.5		 1hxbB-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  84
 None
 0.65A 1hxwA-1q9pA:
10.2		 1hxwA-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.55A 1hxwB-1q9pA:
10.4		 1hxwB-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.35A 1k6cB-1q9pA:
10.8		 1k6cB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.91A 1k6cB-1q9pA:
10.8		 1k6cB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.79A 1muiA-1q9pA:
10.4		 1muiA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.81A 1muiB-1q9pA:
10.5		 1muiB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 1n49B-1q9pA:
10.5		 1n49B-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.71A 1n49C-1q9pA:
10.4		 1n49C-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.92A 1ohrA-1q9pA:
10.6		 1ohrA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.90A 1rl8A-1q9pA:
9.8		 1rl8A-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.87A 1rl8B-1q9pA:
9.8		 1rl8B-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.49A 1rl8B-1q9pA:
9.8		 1rl8B-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.46A 1sdtB-1q9pA:
10.2		 1sdtB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.48A 1sduB-1q9pA:
9.9		 1sduB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.46A 1sdvB-1q9pA:
10.1		 1sdvB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.96A 1sdvB-1q9pA:
10.1		 1sdvB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.36A 1sguB-1q9pA:
9.9		 1sguB-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 8 ASP A  25
ALA A  28
ASP A  29
PRO A  81
 None
 0.64A 1sh9A-1q9pA:
10.4		 1sh9A-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.48A 1t3rA-1q9pA:
10.2		 1t3rA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.59A 1t3rB-1q9pA:
9.9		 1t3rB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.49A 1t7iA-1q9pA:
10.6		 1t7iA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
 None
 0.51A 1t7iB-1q9pA:
10.1		 1t7iB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.43A 1t7jA-1q9pA:
10.9		 1t7jA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
 None
 0.45A 1t7jB-1q9pA:
10.6		 1t7jB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.85A 2aquA-1q9pA:
10.3		 2aquA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.85A 2aquB-1q9pA:
10.1		 2aquB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.47A 2avoB-1q9pA:
10.0		 2avoB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.86A 2avoB-1q9pA:
10.0		 2avoB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.43A 2avsA-1q9pA:
10.1		 2avsA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.47A 2avsB-1q9pA:
9.8		 2avsB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.39A 2avvA-1q9pA:
10.3		 2avvA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.58A 2avvB-1q9pA:
10.3		 2avvB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.92A 2avvB-1q9pA:
10.3		 2avvB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 2avvD-1q9pA:
10.4		 2avvD-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.71A 2avvD-1q9pA:
10.4		 2avvD-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.65A 2avvE-1q9pA:
10.4		 2avvE-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.46A 2avvE-1q9pA:
10.4		 2avvE-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.76A 2b60A-1q9pA:
10.1		 2b60A-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.46A 2b60A-1q9pA:
10.1		 2b60A-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.49A 2b60B-1q9pA:
10.1		 2b60B-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.78A 2b60B-1q9pA:
10.1		 2b60B-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.38A 2b7zA-1q9pA:
10.0		 2b7zA-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.38A 2b7zB-1q9pA:
9.9		 2b7zB-1q9pA:
86.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BL9_A_CP6A1240_1
(DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ILE A  63
ALA A  71
LEU A  89
ILE A  33
ILE A  62
 None
 0.86A 2bl9A-1q9pA:
undetectable		 2bl9A-1q9pA:
17.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.70A 2bpxB-1q9pA:
10.7		 2bpxB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.50A 2f80A-1q9pA:
10.1		 2f80A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.48A 2f80B-1q9pA:
10.2		 2f80B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.56A 2f81A-1q9pA:
9.8		 2f81A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.56A 2f81B-1q9pA:
10.0		 2f81B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 2f8gA-1q9pA:
10.1		 2f8gA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.77A 2f8gB-1q9pA:
10.1		 2f8gB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.57A 2f8gB-1q9pA:
10.1		 2f8gB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.46A 2fxeA-1q9pA:
10.0		 2fxeA-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.70A 2fxeA-1q9pA:
10.0		 2fxeA-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.52A 2fxeB-1q9pA:
9.8		 2fxeB-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.47A 2hs1A-1q9pA:
9.4		 2hs1A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_B_017B203_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 PRO A  44
MET A  46
ARG A  57
GLY A  78
 None
 0.91A 2hs1B-1q9pA:
10.1		 2hs1B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.53A 2hs2A-1q9pA:
9.7		 2hs2A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.45A 2hs2B-1q9pA:
10.2		 2hs2B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.54A 2idwA-1q9pA:
10.1		 2idwA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.54A 2idwB-1q9pA:
10.0		 2idwB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.90A 2ienA-1q9pA:
10.0		 2ienA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.59A 2ienB-1q9pA:
10.1		 2ienB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
 None
 0.93A 2ieoA-1q9pA:
10.0		 2ieoA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.44A 2ieoB-1q9pA:
10.2		 2ieoB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 1.48A 2nmyA-1q9pA:
10.7		 2nmyA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.68A 2nmyA-1q9pA:
10.7		 2nmyA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
ILE A  84
 None
 0.97A 2nmyA-1q9pA:
10.7		 2nmyA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.40A 2nmyB-1q9pA:
10.9		 2nmyB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.70A 2nmyB-1q9pA:
10.9		 2nmyB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.77A 2nmzA-1q9pA:
10.1		 2nmzA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.56A 2nmzB-1q9pA:
9.9		 2nmzB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.51A 2nnkA-1q9pA:
10.1		 2nnkA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.69A 2nnkA-1q9pA:
10.1		 2nnkA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ASP A  29
ASP A  30
PRO A  81
 None
 0.63A 2nnkB-1q9pA:
10.3		 2nnkB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.71A 2nnpA-1q9pA:
10.2		 2nnpA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.94A 2o4kB-1q9pA:
10.4		 2o4kB-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.47A 2o4lA-1q9pA:
10.2		 2o4lA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.51A 2o4lB-1q9pA:
10.4		 2o4lB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.57A 2o4sA-1q9pA:
10.4		 2o4sA-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.49A 2o4sB-1q9pA:
10.2		 2o4sB-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.76A 2pymA-1q9pA:
10.3		 2pymA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.70A 2pymB-1q9pA:
10.3		 2pymB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 2pynA-1q9pA:
10.6		 2pynA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.50A 2pynB-1q9pA:
10.6		 2pynB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.59A 2pynB-1q9pA:
10.6		 2pynB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.49A 2q5kA-1q9pA:
10.8		 2q5kA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.53A 2q5kB-1q9pA:
10.2		 2q5kB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.78A 2q5kB-1q9pA:
10.2		 2q5kB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.77A 2q63A-1q9pA:
10.3		 2q63A-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.72A 2q63B-1q9pA:
10.4		 2q63B-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 2q64A-1q9pA:
10.2		 2q64A-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.52A 2q64B-1q9pA:
10.2		 2q64B-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_4
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.65A 2q64B-1q9pA:
10.3		 2q64B-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.74A 2qakA-1q9pA:
10.2		 2qakA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.53A 2qakB-1q9pA:
10.3		 2qakB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.60A 2qakB-1q9pA:
10.2		 2qakB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 2qhcA-1q9pA:
10.1		 2qhcA-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.71A 2qhcB-1q9pA:
10.1		 2qhcB-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 2qhcB-1q9pA:
10.1		 2qhcB-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.48A 2r5pB-1q9pA:
9.9		 2r5pB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.97A 2r5pB-1q9pA:
9.9		 2r5pB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.48A 2r5pD-1q9pA:
10.0		 2r5pD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.90A 2r5pD-1q9pA:
10.0		 2r5pD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.66A 2r5qB-1q9pA:
10.0		 2r5qB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.89A 2r5qB-1q9pA:
10.0		 2r5qB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.65A 2r5qD-1q9pA:
10.0		 2r5qD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.89A 2r5qD-1q9pA:
10.0		 2r5qD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.48A 2rkfA-1q9pA:
10.5		 2rkfA-1q9pA:
82.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.85A 2rkfB-1q9pA:
10.4		 2rkfB-1q9pA:
82.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.82A 2rkgA-1q9pA:
10.5		 2rkgA-1q9pA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.44A 2rkgB-1q9pA:
10.5		 2rkgB-1q9pA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.75A 2rkgB-1q9pA:
10.5		 2rkgB-1q9pA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.72A 2z54A-1q9pA:
10.0		 2z54A-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.54A 2z54A-1q9pA:
10.0		 2z54A-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.81A 2z54B-1q9pA:
10.0		 2z54B-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.73A 3bvbA-1q9pA:
10.0		 3bvbA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3bvbB-1q9pA:
10.2		 3bvbB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.53A 3cywA-1q9pA:
10.0		 3cywA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.63A 3cywA-1q9pA:
10.0		 3cywA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 3cywB-1q9pA:
10.3		 3cywB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.60A 3cyxA-1q9pA:
9.9		 3cyxA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.41A 3cyxB-1q9pA:
10.2		 3cyxB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.73A 3cyxB-1q9pA:
10.2		 3cyxB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.79A 3d1xA-1q9pA:
10.2		 3d1xA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.42A 3d1xB-1q9pA:
10.1		 3d1xB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.84A 3d1yA-1q9pA:
10.1		 3d1yA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.61A 3d1zA-1q9pA:
10.1		 3d1zA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3d1zB-1q9pA:
10.1		 3d1zB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3d20A-1q9pA:
10.1		 3d20A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.53A 3d20B-1q9pA:
10.3		 3d20B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.58A 3ebzA-1q9pA:
9.6		 3ebzA-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.54A 3ebzB-1q9pA:
9.6		 3ebzB-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.48A 3ekpA-1q9pA:
10.7		 3ekpA-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.77A 3ekpB-1q9pA:
10.6		 3ekpB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.49A 3ekpB-1q9pA:
10.6		 3ekpB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.86A 3ekpC-1q9pA:
10.3		 3ekpC-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.53A 3ekpD-1q9pA:
10.4		 3ekpD-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.61A 3ekqA-1q9pA:
10.4		 3ekqA-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.04A 3ekqA-1q9pA:
10.4		 3ekqA-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.52A 3ektA-1q9pA:
10.4		 3ektA-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.83A 3ektB-1q9pA:
10.3		 3ektB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 3ektB-1q9pA:
10.3		 3ektB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.81A 3ektC-1q9pA:
10.7		 3ektC-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 3ektC-1q9pA:
10.7		 3ektC-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3ektD-1q9pA:
10.7		 3ektD-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 3ekvA-1q9pA:
10.3		 3ekvA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.57A 3ekvB-1q9pA:
10.2		 3ekvB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.43A 3ekwB-1q9pA:
10.4		 3ekwB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
THR A  80
PRO A  81
ILE A  84
 None
 0.68A 3ekxA-1q9pA:
10.6		 3ekxA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.79A 3ekxB-1q9pA:
10.4		 3ekxB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.51A 3ekyA-1q9pA:
10.3		 3ekyA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.57A 3el0A-1q9pA:
10.7		 3el0A-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.58A 3el0A-1q9pA:
10.7		 3el0A-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 GLY A  27
ALA A  28
THR A  80
PRO A  81
ILE A  84
 None
 0.76A 3el0A-1q9pA:
10.7		 3el0A-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.65A 3el1A-1q9pA:
10.4		 3el1A-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.73A 3el1B-1q9pA:
10.6		 3el1B-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.68A 3el4A-1q9pA:
10.7		 3el4A-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
THR A  80
PRO A  81
 None
 0.71A 3el5B-1q9pA:
10.3		 3el5B-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 8 ASP A  25
ALA A  28
ASP A  29
PRO A  81
 None
 0.68A 3el9A-1q9pA:
10.4		 3el9A-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.45A 3em3A-1q9pA:
10.5		 3em3A-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.77A 3em3B-1q9pA:
10.3		 3em3B-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.41A 3em4A-1q9pA:
10.4		 3em4A-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.77A 3em4A-1q9pA:
10.4		 3em4A-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.77A 3em4B-1q9pA:
10.6		 3em4B-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.49A 3em4U-1q9pA:
10.5		 3em4U-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.83A 3em4U-1q9pA:
10.5		 3em4U-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.45A 3em6A-1q9pA:
10.6		 3em6A-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 3em6B-1q9pA:
10.3		 3em6B-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
 None
 0.46A 3gguA-1q9pA:
9.8		 3gguA-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.40A 3gguB-1q9pA:
9.8		 3gguB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.59A 3jvyA-1q9pA:
10.2		 3jvyA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.54A 3jvyA-1q9pA:
10.2		 3jvyA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.45A 3jvyB-1q9pA:
10.4		 3jvyB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.72A 3jw2A-1q9pA:
10.3		 3jw2A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.48A 3jw2A-1q9pA:
10.3		 3jw2A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 3jw2A-1q9pA:
10.3		 3jw2A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.46A 3jw2B-1q9pA:
10.4		 3jw2B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.90A 3k4vA-1q9pA:
10.0		 3k4vA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.80A 3k4vB-1q9pA:
10.1		 3k4vB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 3k4vC-1q9pA:
10.1		 3k4vC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.59A 3k4vD-1q9pA:
10.0		 3k4vD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.80A 3k4vD-1q9pA:
10.0		 3k4vD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 3lzsA-1q9pA:
9.9		 3lzsA-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.53A 3lzsB-1q9pA:
9.8		 3lzsB-1q9pA:
88.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.53A 3lzuA-1q9pA:
9.7		 3lzuA-1q9pA:
87.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.72A 3lzuB-1q9pA:
9.7		 3lzuB-1q9pA:
87.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.58A 3lzuB-1q9pA:
9.7		 3lzuB-1q9pA:
87.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.69A 3lzvB-1q9pA:
10.6		 3lzvB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.53A 3mwsA-1q9pA:
9.6		 3mwsA-1q9pA:
78.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 3mwsB-1q9pA:
9.6		 3mwsB-1q9pA:
78.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.53A 3n3iA-1q9pA:
6.8		 3n3iA-1q9pA:
70.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.67A 3ndtA-1q9pA:
10.2		 3ndtA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.72A 3ndtB-1q9pA:
10.3		 3ndtB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.44A 3ndtC-1q9pA:
10.3		 3ndtC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.52A 3ndtC-1q9pA:
10.3		 3ndtC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.54A 3ndtD-1q9pA:
10.2		 3ndtD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 3ndtD-1q9pA:
10.2		 3ndtD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.55A 3nduA-1q9pA:
10.1		 3nduA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.66A 3nduA-1q9pA:
10.1		 3nduA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.55A 3nduB-1q9pA:
10.1		 3nduB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.67A 3nduB-1q9pA:
10.1		 3nduB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.73A 3nduC-1q9pA:
10.1		 3nduC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.60A 3nduD-1q9pA:
9.8		 3nduD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.74A 3nduD-1q9pA:
9.8		 3nduD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.54A 3ndwA-1q9pA:
10.3		 3ndwA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.54A 3ndxA-1q9pA:
10.2		 3ndxA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.58A 3ndxB-1q9pA:
9.9		 3ndxB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.43A 3nu3A-1q9pA:
9.9		 3nu3A-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 3nu3B-1q9pA:
10.2		 3nu3B-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.64A 3nu4A-1q9pA:
10.0		 3nu4A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.48A 3nu4B-1q9pA:
10.2		 3nu4B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.82A 3nu5A-1q9pA:
9.9		 3nu5A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 3nu5B-1q9pA:
10.2		 3nu5B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.52A 3nu6A-1q9pA:
10.1		 3nu6A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.45A 3nu6B-1q9pA:
10.2		 3nu6B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.61A 3nu9A-1q9pA:
10.2		 3nu9A-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
 None
 0.38A 3nu9B-1q9pA:
10.3		 3nu9B-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.68A 3nujA-1q9pA:
10.0		 3nujA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.49A 3nujB-1q9pA:
10.1		 3nujB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 3nuoA-1q9pA:
9.9		 3nuoA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3nuoB-1q9pA:
10.2		 3nuoB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.64A 3oxcA-1q9pA:
10.7		 3oxcA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.53A 3oxcB-1q9pA:
10.7		 3oxcB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.49A 3oxvA-1q9pA:
10.4		 3oxvA-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 3oxvB-1q9pA:
10.2		 3oxvB-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.49A 3oxvC-1q9pA:
10.4		 3oxvC-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.70A 3oxvD-1q9pA:
10.2		 3oxvD-1q9pA:
90.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.48A 3oxwA-1q9pA:
10.4		 3oxwA-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 3oxwB-1q9pA:
10.3		 3oxwB-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.41A 3oxwC-1q9pA:
10.5		 3oxwC-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.85A 3oxwD-1q9pA:
10.2		 3oxwD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.51A 3oxxA-1q9pA:
10.6		 3oxxA-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.45A 3oxxC-1q9pA:
10.3		 3oxxC-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.81A 3oxxD-1q9pA:
10.7		 3oxxD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.60A 3oy4A-1q9pA:
10.4		 3oy4A-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.56A 3oy4B-1q9pA:
10.6		 3oy4B-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.55A 3pwmA-1q9pA:
10.0		 3pwmA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.57A 3pwmB-1q9pA:
10.1		 3pwmB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.58A 3pwrA-1q9pA:
10.0		 3pwrA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.65A 3pwrA-1q9pA:
10.0		 3pwrA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.49A 3pwrB-1q9pA:
10.2		 3pwrB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.48A 3s43B-1q9pA:
10.3		 3s43B-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.67A 3s45A-1q9pA:
9.7		 3s45A-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.49A 3s45B-1q9pA:
9.8		 3s45B-1q9pA:
49.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.47A 3s53A-1q9pA:
9.6		 3s53A-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.86A 3s54A-1q9pA:
10.2		 3s54A-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.50A 3s54B-1q9pA:
10.3		 3s54B-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.57A 3s56A-1q9pA:
9.9		 3s56A-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
 None
 0.64A 3s56A-1q9pA:
9.9		 3s56A-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.52A 3so9A-1q9pA:
9.9		 3so9A-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 LEU A  23
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.84A 3so9B-1q9pA:
10.1		 3so9B-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.49A 3t3cA-1q9pA:
9.3		 3t3cA-1q9pA:
73.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.48A 3t3cA-1q9pA:
9.3		 3t3cA-1q9pA:
73.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.77A 3t3cB-1q9pA:
9.1		 3t3cB-1q9pA:
73.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.55A 3tkgA-1q9pA:
10.3		 3tkgA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.70A 3tkgA-1q9pA:
10.3		 3tkgA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.46A 3tkgB-1q9pA:
10.0		 3tkgB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
ILE A  84
 None
 0.72A 3tkgB-1q9pA:
10.0		 3tkgB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.59A 3tkgC-1q9pA:
10.2		 3tkgC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
ILE A  84
 None
 0.59A 3tkgC-1q9pA:
10.2		 3tkgC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
THR A  80
PRO A  81
ILE A  84
 None
 0.73A 3tkgC-1q9pA:
10.2		 3tkgC-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.55A 3tkgD-1q9pA:
10.0		 3tkgD-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.50A 3tkwA-1q9pA:
10.2		 3tkwA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.45A 3tkwB-1q9pA:
10.4		 3tkwB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.89A 3tkwB-1q9pA:
10.4		 3tkwB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.81A 3tl9A-1q9pA:
10.1		 3tl9A-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_3
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.69A 3tl9B-1q9pA:
10.5		 3tl9B-1q9pA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TQ8_A_TOPA2001_1
(DIHYDROFOLATE
REDUCTASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ILE A  63
ALA A  71
LEU A  89
ILE A  33
ILE A  62
 None
 0.94A 3tq8A-1q9pA:
undetectable		 3tq8A-1q9pA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TQ9_A_MTXA2001_1
(DIHYDROFOLATE
REDUCTASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ILE A  63
ALA A  71
LEU A  89
ILE A  33
ILE A  62
 None
 0.95A 3tq9A-1q9pA:
undetectable		 3tq9A-1q9pA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.46A 3ttpA-1q9pA:
10.0		 3ttpA-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
LEU A  23
ILE A  84
 None
 1.38A 3ttpA-1q9pA:
10.0		 3ttpA-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.86A 3ttpA-1q9pA:
10.0		 3ttpA-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.49A 3ttpB-1q9pA:
10.0		 3ttpB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
LEU A  23
ILE A  84
 None
 1.39A 3ttpB-1q9pA:
10.0		 3ttpB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.88A 3ttpB-1q9pA:
10.0		 3ttpB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.45A 3u7sA-1q9pA:
10.4		 3u7sA-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.44A 3u7sB-1q9pA:
10.3		 3u7sB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 MET A  46
LYS A  55
GLY A  78
PRO A  79
 None
 1.38A 3ucbB-1q9pA:
9.6		 3ucbB-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 7 PRO A  44
MET A  46
ARG A  57
GLY A  78
PRO A  79
 None
 0.95A 3ucbB-1q9pA:
9.6		 3ucbB-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 TRP A  42
PRO A  44
MET A  46
PRO A  79
 None
 1.06A 3ucbB-1q9pA:
9.6		 3ucbB-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
 None
 0.78A 3ufnA-1q9pA:
9.7		 3ufnA-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.51A 3wsjA-1q9pA:
7.9		 3wsjA-1q9pA:
33.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 8 TYR A  59
VAL A  75
ILE A  64
GLU A  35
 None
 1.10A 4a97D-1q9pA:
undetectable		 4a97D-1q9pA:
16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 TYR A  59
VAL A  75
ILE A  64
GLU A  35
 None
 1.09A 4a97H-1q9pA:
undetectable		 4a97H-1q9pA:
16.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.78A 4dqbA-1q9pA:
10.0		 4dqbA-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.52A 4dqbB-1q9pA:
10.0		 4dqbB-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.80A 4dqcA-1q9pA:
10.1		 4dqcA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.47A 4dqcB-1q9pA:
10.2		 4dqcB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.77A 4dqeA-1q9pA:
10.1		 4dqeA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.49A 4dqeB-1q9pA:
10.1		 4dqeB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 4dqfA-1q9pA:
9.5		 4dqfA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.54A 4dqfB-1q9pA:
9.7		 4dqfB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.78A 4dqhA-1q9pA:
10.0		 4dqhA-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.53A 4dqhB-1q9pA:
10.1		 4dqhB-1q9pA:
95.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EYR_B_RITB301_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.34A 4eyrB-1q9pA:
10.2		 4eyrB-1q9pA:
83.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.51A 4hlaA-1q9pA:
10.1		 4hlaA-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.47A 4hlaB-1q9pA:
10.0		 4hlaB-1q9pA:
94.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.44A 4jecA-1q9pA:
10.5		 4jecA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.66A 4jecB-1q9pA:
10.3		 4jecB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.71A 4l1aA-1q9pA:
8.9		 4l1aA-1q9pA:
83.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.89A 4ll3A-1q9pA:
10.1		 4ll3A-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.59A 4ll3A-1q9pA:
10.1		 4ll3A-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.54A 4ll3B-1q9pA:
10.1		 4ll3B-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.55A 4ll3A-1q9pA:
10.1		 4ll3A-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.90A 4ll3B-1q9pA:
10.1		 4ll3B-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 4njtA-1q9pA:
10.1		 4njtA-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.56A 4njtB-1q9pA:
10.4		 4njtB-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.64A 4njtC-1q9pA:
10.2		 4njtC-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.58A 4njtD-1q9pA:
10.4		 4njtD-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
 None
 0.81A 4njuA-1q9pA:
10.3		 4njuA-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
 None
 0.82A 4njuC-1q9pA:
10.3		 4njuC-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.75A 4njvA-1q9pA:
10.4		 4njvA-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 11 ASP A  25
GLY A  27
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.68A 4njvB-1q9pA:
10.9		 4njvB-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ASP A  29
VAL A  32
PRO A  81
ILE A  84
 None
 0.86A 4njvC-1q9pA:
10.4		 4njvC-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.60A 4njvD-1q9pA:
10.9		 4njvD-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.49A 4q1wA-1q9pA:
10.6		 4q1wA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.66A 4q1wB-1q9pA:
10.2		 4q1wB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.45A 4q1xA-1q9pA:
10.5		 4q1xA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.55A 4q1xB-1q9pA:
10.4		 4q1xB-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.47A 4q1yA-1q9pA:
10.6		 4q1yA-1q9pA:
91.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.67A 4qgiA-1q9pA:
10.2		 4qgiA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.55A 4qgiB-1q9pA:
10.3		 4qgiB-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 4rvjA-1q9pA:
10.0		 4rvjA-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.52A 4rvjB-1q9pA:
10.5		 4rvjB-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 4rvjC-1q9pA:
10.0		 4rvjC-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 4rvjD-1q9pA:
10.5		 4rvjD-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.43A 5e5jA-1q9pA:
10.5		 5e5jA-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.68A 5e5jB-1q9pA:
10.5		 5e5jB-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.49A 5e5kA-1q9pA:
10.6		 5e5kA-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.43A 5e5kB-1q9pA:
10.4		 5e5kB-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.67A 5kqxA-1q9pA:
10.3		 5kqxA-1q9pA:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		4 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.42A 5kqyB-1q9pA:
10.2		 5kqyB-1q9pA:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_2
(PROTEASE PR5-DRV)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.47A 5kr1B-1q9pA:
10.0		 5kr1B-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.57A 5kr2A-1q9pA:
10.0		 5kr2A-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 9 ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.49A 5kr2C-1q9pA:
10.0		 5kr2C-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.89A 5t2zA-1q9pA:
9.8		 5t2zA-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.55A 5t2zA-1q9pA:
9.8		 5t2zA-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 5t2zB-1q9pA:
9.8		 5t2zB-1q9pA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.42A 5t8hA-1q9pA:
10.6		 5t8hA-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.68A 5t8hB-1q9pA:
10.3		 5t8hB-1q9pA:
96.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.48A 6dgxA-1q9pA:
10.4		 6dgxA-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ALA A  28
ASP A  30
VAL A  32
LEU A  76
ILE A  84
 None
 0.74A 6dgxB-1q9pA:
10.2		 6dgxB-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.56A 6dgxB-1q9pA:
10.2		 6dgxB-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.64A 6dgxB-1q9pA:
10.2		 6dgxB-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.48A 6dh0A-1q9pA:
10.2		 6dh0A-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
 None
 0.52A 6dh0B-1q9pA:
10.1		 6dh0B-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.49A 6dh3A-1q9pA:
10.4		 6dh3A-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.67A 6dh3B-1q9pA:
10.6		 6dh3B-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.56A 6dh3B-1q9pA:
10.6		 6dh3B-1q9pA:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.51A 6dh6A-1q9pA:
10.3		 6dh6A-1q9pA:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.65A 6dh6B-1q9pA:
10.2		 6dh6B-1q9pA:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
 None
 0.58A 6dh6B-1q9pA:
10.2		 6dh6B-1q9pA:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.45A 6difA-1q9pA:
10.2		 6difA-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.41A 6difB-1q9pA:
10.2		 6difB-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.53A 6dilA-1q9pA:
10.2		 6dilA-1q9pA:
98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  84
 None
 0.39A 6dilB-1q9pA:
10.2		 6dilB-1q9pA:
98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
 None
 0.60A 6dj1A-1q9pA:
10.1		 6dj1A-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.38A 6dj1B-1q9pA:
10.1		 6dj1B-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.81A 6dj1B-1q9pA:
10.1		 6dj1B-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  84
 None
 0.57A 6dj2A-1q9pA:
10.1		 6dj2A-1q9pA:
98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		5 / 10 ASP A  25
ALA A  28
VAL A  32
PRO A  81
ILE A  84
 None
 0.80A 6dj2A-1q9pA:
10.1		 6dj2A-1q9pA:
98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
 None
 0.41A 6dj2B-1q9pA:
10.1		 6dj2B-1q9pA:
98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 1q9p HIV-1 PROTEASE
(Homo
sapiens) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.79A 6dj2B-1q9pA:
10.1		 6dj2B-1q9pA:
98.75